Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZYMERGEN INC.

(ZY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Zymergen : UBS Downgrades Zymergen to Neutral From Buy, Adjusts Price Target to $13 From $56

08/31/2021 | 07:25am EDT


© MT Newswires 2021
All news about ZYMERGEN INC.
10/06ZYMERGEN : Shares Fall to Lowest Level Since August Amid Low Trading Volume
MT
10/01ZYMERGEN 72 HOUR DEADLINE ALERT : Former Louisiana Attorney General and Kahn Swick & Foti,..
BU
10/01ZYMERGEN 24 HOUR DEADLINE ALERT : FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI,..
PR
10/01DEADLINE ALERT : Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit..
BU
10/01THE LAW OFFICES OF FRANK R. CRUZ : Reminds Investors of Looming Deadline in the Class Acti..
BU
10/01MONDAY DEADLINE FOR SHAREHOLDERS TO : Bronstein, Gewirtz & Grossman, LLC
BU
09/30KESSLER TOPAZ MELTZER & CHECK, LLP : Important Deadline Reminder for Zymergen Inc. Investo..
BU
09/29SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymer..
PR
09/29Zymergen Inc. Announces the Resignation of Josh Hoffman as Chief Executive Officer
CI
09/29Zymergen Inc. Announces the Resignation of Josh Hoffman as a Board Member
CI
More news
Analyst Recommendations on ZYMERGEN INC.
More recommendations
Financials (USD)
Sales 2021 15,5 M - -
Net income 2021 -336 M - -
Net cash 2021 351 M - -
P/E ratio 2021 -4,31x
Yield 2021 -
Capitalization 1 316 M 1 316 M -
EV / Sales 2021 62,1x
EV / Sales 2022 80,0x
Nbr of Employees 758
Free-Float 91,1%
Chart ZYMERGEN INC.
Duration : Period :
Zymergen Inc. Technical Analysis Chart | ZY | US98985X1000 | MarketScreener
Technical analysis trends ZYMERGEN INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 7
Last Close Price 12,85 $
Average target price 10,40 $
Spread / Average Target -19,1%
EPS Revisions
Managers and Directors
Jay T. Flatley Chairman & Chief Executive Officer
Enakshi Singh Chief Financial Officer
Zachariah Serber Director & Chief Science Officer
Jed Dean Vice President-Operations & Engineering
Aaron Kimball Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
ZYMERGEN INC.0.00%1 316
SHIN-ETSU CHEMICAL CO., LTD.9.17%71 635
BASF SE0.43%69 259
DUPONT DE NEMOURS, INC.1.35%37 697
ROYAL DSM N.V.29.90%36 184
PIDILITE INDUSTRIES LIMITED40.49%16 809